Florida Department of HealthEPI UPDATE

A Publication by the Bureau of Epidemiology

 

November 30, 2001

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

 

Steven T. Wiersma, MD, MPH—Bureau Chief and State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Samuel Crane, MPH, Special Projects Surveillance Coordinator, Epi Update Editor

 

Bureau of Epidemiology Frequent Contributors:

Kathryn Snavely, MPH

Reportable Disease Manager

Jodi Baldy, MPH,

Biological Scientist IV

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

 

Regional Epidemiologists:

Dolly Katz, PhD, MPH, SE Florida

Roger Sanderson, RN, MA, SW Florida

Carina Blackmore, MS Vet. Med., PhD, NE Florida

Zuber Mulla, PhD MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

 

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

The Department of Health has a home on the World Wide Web at http://www.doh.state.fl.us

For information on diseases and conditions of public health importance go to MyFlorida.com, click on Health and Human Services, then Consumers--Diseases and Conditions.

In this issue:

  1. Update: Florida West Nile Surveillance
  2. Smallpox Reference Link
  3. Bush Administration Orders Smallpox Vaccine
  4. Bioterrorism Training Opportunities
  5. Weekly Disease Table (47)

 

1. Florida West Nile Virus Surveillance Update – 11/29/01

Robin Oliveri, Arbovirus Surveillance Coordinator

Weekly arbovirus surveillance maps and data summary tables demonstrating dead bird surveillance results, sentinel chicken data and comprehensive arbovirus surveillance data are available through the Bureau of Epidemiology website at the following address: http://www.doh.state.fl.us/Disease_ctrl/epi/htopics/arbo/index.htm , then choose either "surveillance information" or "maps".

Table 1: Summary of West Nile Positive Data as of November 29, 2001 since last summary report on November 19, 2001.

COUNTY

HUMAN

NEW

BIRDS

NEW

HORSES

NEW

SENTINEL CHICKENS

NEW

Alachua

25

6

39

20

Baker

2

6

 

Bay

47

11

4

10

Bradford

15

3

9

 

Brevard

 

1

Broward

2

1

1

 

Calhoun

5

 

Charlotte

3

 

Citrus

7

1

3

2

Clay

25

8

36

 

Collier

2

1

2

1

Columbia

19

11

 

Dade

15

5

 

DeSoto

 

 

Dixie

1

 

Duval

1

64

5

27

30

Escambia

7

4

 

Flagler

1

2

 

Franklin

3

 

Gadsden

15

6

 

Gilchrist

6

4

 

Glades

 1

1

 

Gulf

7

1

3

 

Hamilton

14

1

 

Hardee

 

 

Hendry

 

 

Hernando

4

2

2

 

Highlands

1

 

Hillsborough

1

1

2

Holmes

12

7

 

Indian River

 

1

1

Jackson

5

3

2

 

Jefferson

1

14

40

1

Lafayette

5

3

 

Lake

8

4

4

 

Lee

2

3

Leon

1

88

2

30

53

1

Levy

9

1

8

 

Liberty

7

 

Madison

2

9

9

 

Manatee

1

 

Marion

25

19

49

 

Martin

2

2

8

Monroe

2

14

 

Nassau

19

11

 

Okaloosa

15

6

1

 

Okeechobee

1

1

Orange

1

 

Osceola

 

2

Palm Beach

1

4

3

Pasco

12

1

1

Pinellas

 

2

Polk

3

2

1

Putnam

1

5

1

7

8

Santa Rosa

6

 

Sarasota

1

3

3

 

Seminole

2

1

St. Johns

 

13

17

4

St. Lucie

 

 

Sumter

1

3

 

Suwannee

33

2

20

3

Taylor

11

17

 

Union

6

1

 

Volusia

1

1

 

Walton

3

1

1

5

Wakulla

60

1

11

 

Washington

1

13

8

 

UNKNOWN

2

1

 

Totals

10

691

98

404

177

7

 

2. Smallpox Reference Link

The UC Berkeley Public Health Library discovered that WHO has published its out-of-print 1400+ page book, "Smallpox and its eradication" by Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID:

Chapter 1, "Clinical features," contains extensive color photographs of typical/ordinary, modified, flat and hemorrhagic variants of smallpox (pp. 7-36). These images might be useful for many groups, including clinicians, and local health departments.

http://www.who.int/emc/diseases/smallpox/Smallpoxeradication.html

 

 

3. Bush Administration Orders Smallpox Vaccine

Samuel Crane, MPH, Bureau of Epidemiology

The Bush administration secured a contract Wednesday with Acambis Inc., who will provide 155 million doses of smallpox vaccine to the nation‘s stockpile. The contract was finally signed after HHS officials had been negotiating for weeks with Acambis and several other pharmaceutical manufacturers including, Merck & Co. and GlaxoSmithKline.

Currently, the government has 15.4 million doses of smallpox vaccine. Researchers have shown that diluting the vaccine is safe and effective. Plans are being made to dilute each one to create five doses bringing the total to 77 million. Researchers are still studying whether it would be possible to dilute the current batch even further to 10 doses for each existing dose. Officials have already ordered 54 million doses from Acambis which are expected to be delivered next year. The new contract with Acambis will expand the nation’s stockpile of vaccine to 286 million doses by the end of next year. This would allow health officials to provide a smallpox vaccine to every American citizen. Acambis will share some of the production burden with Baxter International, which will begin producing doses immediately. Research has shown that the vaccine can be administered four days after exposure to smallpox and still offer protection. For that reason and the possible side effects, no plans have been made to resume routine vaccinations which ended in 1972.

The cost to purchase the new 155 million doses is $428 million, or $2.76 per dose. The Bush administration originally asked congress for $509 million to pay for more vaccine. Due to the plans to expand existing vaccine stock by dilution, the government will save nearly $120 million.

 

4. Bioterrorism Training Opportunities

Submitted by: Melanie Black, Professional Training Coordinator, Bureau of Epidemiology, Florida Department of Health

CDC Satellite Broadcasts

"CDC Responds: Risk Communication and Bioterrorism"
Thursday, December 6, 2001
1:00 PM – 2:30 PM

This live satellite and web broadcast will address the following topics: forming your public information messages about health risks caused by an act of bioterrorism; responding to public concerns at the local, state and federal levels; and issues of concern when a public health investigation and a criminal investigation converge.

"Smallpox: What Every Clinician Should Know"
Thursday, December 13, 2001
12:00 PM – 2:00 PM

Because of concerns that smallpox virus could be used as an agent of bioterrorism, providers should be familiar with the disease and the vaccine to prevent it. This live satellite broadcast will present information on virology, epidemiology, clinical features and diagnosis of smallpox, and the characteristics and use of smallpox vaccine.

If you are interest in viewing this program, please contact your site coordinator or you can contact Melanie Black, MSW by email [Melanie_Black@doh.state.fl.us] or by phone (850) 245-4444 ext. 2448, SunCom 205-4444 ext. 2448.

 

5. Weekly Disease Table (Week 47)

DISEASE

1999 TO
WEEK 47

2000 TO
WEEK 47

3-YEAR
AVERAGE
TO WEEK 47*

2000
TOTAL
CASES

2001 TO
WEEK 47

2001
WEEK 47
ONLY

ANIMAL BITE, PEP RECOMMENDED

148

277

469

477

982

7

ANIMAL RABIES

172

147

169

161

187

0

ANTHRAX

0

0

1

0

2

0

BOTULISM, FOODBORNE

3

0

1

0

0

0

BRUCELLOSIS

2

5

3

6

3

0

CAMPYLOBACTERIOSIS

841

869

840

1049

811

11

CIGUATERA

2

14

9

14

10

0

CRYPTOSPORIDIOSIS

149

205

145

239

82

0

CYCLOSPORIASIS

8

6

21

9

48

0

DENGUE FEVER

5

5

6

10

9

0

EHRLICHIOSIS, HUMAN

7

0

2

0

0

0

EHRLICHIOSIS, HUMAN MONOCYTIC

0

6

4

10

6

2

ENCEPHALITIS, CHICKENPOX

0

0

0

1

0

0

ENCEPHALITIS, EASTERN EQUINE

2

0

2

0

3

0

ENCEPHALITIS, HERPES

4

4

4

8

3

0

ENCEPHALITIS, INFLUENZA

0

1

0

1

0

0

ENCEPHALITIS, OTHER

8

8

8

10

9

0

ENCEPHALITIS, ST. LOUIS

3

0

1

0

0

0

ENCEPHALITIS, WEST NILE VIRUS

0

0

3

0

9

1

ESCHERICHIA COLI, O157:H7

66

88

66

98

43

1

ESCHERICHIA COLI, OTHER

13

10

15

14

21

1

GIARDIASIS

1114

1252

1121

1520

996

18

H. INFLUENZAE CELLULITIS

0

1

0

1

0

0

H. INFLUENZAE EPIGLOTTITIS

0

1

0

1

0

0

H. INFLUENZAE MENINGITIS

14

8

10

11

8

1

H. INFLUENZAE PNEUMONIA

5

6

8

7

13

0

H. INFLUENZAE PRIMARY BACTEREMIA

23

38

39

58

57

0

H. INFLUENZAE SEPTIC ARTHRITIS

0

0

0

1

0

0

HANTAVIRUS INFECTION

0

0

0

0

1

0

HEMOLYTIC UREMIC SYNDROME

8

16

10

20

5

0

HEPATITIS A

642

495

621

659

726

35

HEPATITIS B {+HBsAg IN PREGNANT WOMEN}

121

388

296

515

380

7

HEPATITIS B PERINATAL, ACUTE

2

3

4

3

7

0

HEPATITIS B, ACUTE

385

494

442

616

446

11

HEPATITIS B, CHRONIC

0

0

112

0

336

5

HEPATITIS C, ACUTE

43

40

44

48

49

1

HEPATITIS C, CHRONIC

0

0

285

0

856

28

HEPATITIS NANB, ACUTE

11

6

8

6

7

0

HEPATITIS UNSPECIFIED, ACUTE

15

7

9

7

4

0

LEAD POISONING

1531

1053

1055

1237

580

4

LYME DISEASE

48

46

49

54

53

1

MALARIA

73

64

62

90

49

2

MEASLES

2

2

1

2

0

0

MENINGITIS, GROUP B STREP

11

19

15

21

14

2

MENINGITIS, LISTERIA MONOCYTOGENES

8

6

5

7

2

0

MENINGITIS, MENINGOCCOCAL

52

40

50

49

57

2

MENINGITIS, OTHER

50

87

77

112

95

2

MENINGITIS, STREP PNEUMONIAE

84

92

75

113

49

0

MENINGOCOCCEMIA, DISSEMINATED

63

68

64

84

61

0

MERCURY POISONING

4

9

5

11

2

0

MONKEY BITE

0

3

2

6

3

0

MUMPS

14

6

8

7

5

0

PERTUSSIS

92

64

62

67

29

0

PESTICIDE-RELATED ILLNESS OR INJURY

56

15

26

15

7

0

PSITTACOSIS

1

1

1

4

0

0

Q FEVER

0

0

0

0

1

0

ROCKY MOUNTAIN SPOTTED FEVER

7

10

9

12

9

0

RUBELLA

0

2

2

2

3

0

RUBELLA, CONGENITAL

0

1

0

1

0

0

SALMONELLOSIS

2622

2407

2576

2814

2699

59

LEGIONELLOSIS

22

42

50

54

86

1

LEPROSY {HANSENS DISEASE}

3

3

3

4

2

0

LEPTOSPIROSIS

1

2

1

3

1

0

LISTERIOSIS

27

28

24

33

17

2

SHIGELLOSIS

1444

1331

1224

1520

898

9

STREPTOCOCCAL DISEASE INVASIVE GROUP A

63

115

104

147

135

4

STREPTOCOCCUS PNEUMONIAE, INVASIVE DISEASE

501

898

707

1154

722

7

TETANUS

2

1

2

1

3

0

TOXOPLASMOSIS

15

10

17

14

27

0

TRICHINOSIS

1

0

0

1

0

0

TULAREMIA

0

0

0

0

0

0

TYPHOID FEVER

24

10

14

12

9

0

VIBRIO ALGINOLYTICUS

9

16

11

17

8

0

VIBRIO CHOLERAE NON-O1

9

4

6

4

5

0

VIBRIO FLUVIALIS

5

2

4

2

4

0

VIBRIO HOLLISAE

4

3

2

3

0

0

VIBRIO MIMICUS

2

2

2

2

1

0

VIBRIO PARAHAEMOLYTICUS

17

15

15

17

12

0

VIBRIO VULNIFICUS

24

12

18

13

19

1

VIBRIO, OTHER

3

1

2

3

3

0

* The column of data representing the "3-year average to week ##" is the average of years 1998, 1999 and 2000 cases to the current listed week (##)